New Treatments for Type 2 diabetes. Nandini Seevaratnam April 2016 Rushcliffe Patient Forum
|
|
- Steven Hawkins
- 5 years ago
- Views:
Transcription
1 New Treatments for Type 2 diabetes Nandini Seevaratnam April 2016 Rushcliffe Patient Forum
2 Overview Growing population of Type 2 diabetes Basic science on what goes wrong Current treatments Why there is a need for new treatments
3 Diabetes in the UK Estimates of diabetes Diagnosed Undiagnosed Around People in the UK have diabetes But have not been diagnosed Almost two in every three People in the UK are Overweight or obese M, million Diabetes UK News (More than 700 people a day diagnosed with diabetes; Friday 04 July 2014); Adapted from Diabetes: Facts and Stats. Version 3. Revised March Published by Diabetes UK, 2014.
4 Most common type of diabetes People with type 2 diabetes do not make enough insulin or the insulin they make does not work very well (insulin resistance)
5 The pathophysiology of type 2 diabetes: pancreatic dysfunction Insulin deficiency Islet Pancreas Alpha cell produces excess glucagon Beta cell produces less insulin Excess glucagon Diminished insulin Liver Diminished insulin High Glucose Muscle and fat Excess glucose output Insulin resistance (decreased glucose uptake)
6 Type 2 Diabetes Affects 6% of UK population Blood glucose control is only one aspect of care for Type 2 diabetes Good control is linked to a reduction in risk of complications eg heart attacks, kidney, eye and nerve problems Blood glucose control is measured by Hba1c
7
8 HbA1c Hba1c - longterm blood sugar control indicator, reflects average blood glucose level in the previous 2-3 months A high level means that blood glucose levels have been consistently high over recent weeks and treatment plan may need to be reviewed Ideal target (48-53 mmol/mol) but needs to be individualised Measured 3-6 monthly
9
10 Treatments for Type 2 diabetes Lifestyle diet, weight control and physical activity Tablets Insulin
11 Diet Healthy balanced diet Low in fat, high in fibre, fruit and vegetables If obese or overweight then losing weight will help to reduce blood glucose levels along with other health benefits VLCD (very low calorie diet)
12
13 Educational courses Education programme to adults and carers Diet and exercise Personalised plan to manage diabetes
14 Tablets Metformin Often first tablet advised Can take a few days to see effect (up to 2 weeks) Taken with food (1 to 3 times a day) Lowers blood glucose by decreasing the amount of glucose that your liver releases into the bloodstream Increases the sensitivity of your body s cells to insulin
15 Tablets Metformin Lowers risk of complications such as heart attacks or strokes Useful in those who are overweight as it does not cause weight gain Generally does not cause hypoglycaemia
16 Tablets Metformin Side effects digestive problems (1 in 10) Rare side effect lactic acidosis (1 in 10,000) particularly when dehydrated or prolonged fasting Need to stop when there is a decrease in kidney function Need to stop 3 days before scans eg. CT, MRI
17 Sulphonyurea eg. Gliclazide Increases the amount of insulin that the pancreas makes Often used if metformin is not tolerated Usually once to twice a day Can cause hypoglycaemia but can be avoided with regular meals/avoid missing meals Must home blood glucose monitor if driving
18 Hypoglycaemia Low blood sugars Shaky, sweaty, tremors, hungry, nausea and weak If very low brain runs out of fuel and can cause confusion Treat with glucotabs, 4-5 jelly babies followed by biscuits/toast/cereal Glucagon injection
19 Pioglitazone Lowers blood glucose by making the body more sensitive to insulin Usually used in combination with metformin and/or sulphonyureas Once a day dose Average weight gain 2-3kg over 12 months Should not cause hypoglycaemia
20 Pioglitazone Side effects Bone fracture 1-10 in every 1000 Cannot use in heart failure due to fluid retention Not to be used in those with a history of bladder cancer
21 The pathophysiology of type 2 diabetes: pancreatic dysfunction Insulin deficiency Sulphonylureas Insulin Pancreas Liver Excess glucose output Metformin Pioglitazone High Glucose Muscle and fat Insulin resistance (decreased glucose uptake) Metformin Pioglitazone
22 Effects of Anti-diabetic therapy HbA1c Weight Hypos Metformin / Sulphonylurea Pioglitazone Insulin
23 Barriers to Treatment Treatments are adding to the problem Weight gain Hypoglycaemia risk and fear leads to increased eating/snacking and poor control Adherence to treatment Difficulty in losing weight 80% overweight Newer treatments aid weight loss/neutral - reduce risk of hypoglycaemia
24 3 New Therapies GLP-1 peptides eg. Exenatide, Liraglutide, Lixisenatide Gliptins (DPP4 inhibitors) eg. Sitagliptin, Vildagliptin, Linagliptin SGLT2 inhibitors eg. dapagliflozin, canagliflozin, empagliflozin
25 GLP-1 Effects in Humans GLP-1 secreted upon the ingestion of food Reduces appetite and makes you feel fuller Stops liver from making too much glucose when your body does not need it Signals the pancreas to secrete the right amount of insulin after you eat Slows down how quickly food and glucose leaves the stomach Adapted from Flint A, et al. J Clin Invest. 1998;101: ; Adapted from Larsson H, et al. Acta Physiol Scand. 1997;160: ; Adapted from Nauck MA, et al. Diabetologia. 1996;39: ; Adapted from Drucker DJ. Diabetes. 1998;47:
26 GLP-1 mimetics Similar to hormones produced from the gut which stimulate insulin secretion in response to glucose Slows down stomach emptying encouraging fullness and reduces food intake Leads to modest weight loss Side effects nausea, vomiting, diarrhoea Not to be used in those with a history of pancreatitis or significant bowel surgery
27 GLP-1 mimetics Injectable therapy - once or twice daily - once weekly Often used with metformin /sulphonyurea / pioglitazone and/or insulin in those who are obese Reduced risk of hypoglycaemia Trial of 6 months need to show benefit in weight loss and improved sugar control to continue treatment
28
29 Gliptins (DPP4 inhibitors) DDP4 is an enzyme that breaks down GLP-1 hormone. Works by preventing the breakdown on naturally occurring hormone called GLP-1. GLP-1 helps the body to produce insulin in response to high blood glucose levels By preventing this breakdown help to prevent high blood sugars
30 Gliptins (DPP4 inhibitors) Increases insulin when blood sugars are high Reduces the amount of sugar made by the liver after you eat Improves fasting and after meal blood sugar No hypoglycaemia Not associated with weight gain
31 Gliptins (DPP4 inhibitors) Usually taken once a day Most common side effect runny nose, headache Rare acute pancreatitis (1-10 in 1000) Not to be used if a previous history of pancreatitis
32
33 SGLT2 inhibitors Increase the amount of glucose in your urine and so reduce blood glucose levels Can help to reduce weight On average 2-3kg over 6-12 months Should not cause hypoglycaemia
34 SGLT2 inhibitors Taken once a day Side effects increased risk of genital and urinary tract infections (1-10 in100) Low blood pressure Not to be used in >75 years old Not to be used in those on furosemide Rare diabetic ketoacidosis
35
36 Insulin Often if tablets not effective in lowering blood glucose levels Injections to lower blood glucose levels Type, dose and frequency varies from individual to individual Often used in conjunction with tablet therapy
37 Effects of Anti-diabetic therapy HbA1c Weight Hypos Metformin / Sulphonylurea Glitazone Insulin GLP-1 analogue Gliptin SGLT2- inhibitors
38 Decision Aid What HbA1c target is best for you? What medicine might help to try and achieve this target?
39 Other treatments Healthy Diet Keep active Stop smoking If any treatment that causes hypoglycaemia should be fingerprick testing for glucose levels with blood glucose meter if driving Anti-BP for high blood pressure Statin to reduce high cholesterol Screening eyes, kidneys and feet
40 Thank You For Listening
TREATMENTS FOR TYPE 2 DIABETES. Susan Henry Diabetes Specialist Nurse
TREATMENTS FOR TYPE 2 DIABETES Susan Henry Diabetes Specialist Nurse How can we improve outcomes in Type 2 diabetes? Earlier diagnosis Better patient education Stress central role of lifestyle management
More informationManagement of Type 2 Diabetes
Management of Type 2 Diabetes Pathophysiology Insulin resistance and relative insulin deficiency/ defective secretion Not immune mediated No evidence of β cell destruction Increased risk with age, obesity
More informationType 2 diabetes in adults: controlling your blood glucose by taking a second medicine what are your options?
Patient decision aid Type 2 diabetes in adults: controlling your blood glucose by taking a second medicine what are your options? nice.org.uk/guidance/ng28 Published: December 2015 About this decision
More informationGLP-1 Receptor Agonists and SGLT-2 Inhibitors. Debbie Hicks
GLP-1 Receptor Agonists and SGLT-2 Inhibitors Debbie Hicks Prescribing and Adverse Event reporting information is available at this meeting from the AstraZeneca representative The views expressed by the
More informationDept of Diabetes Main Desk
Dept of Diabetes Main Desk 01202 448060 Glucose management in Type 2 Diabetes in Adults The natural history of type 2 diabetes is for HbA1c to deteriorate with time. A stepwise approach to treatment is
More informationHow they work and when to take them. Diabetes Medications
How they work and when to take them Diabetes Medications BIGUANIDES Metformin Actions Slows down the release of glucose from the liver. Helps the bodies cells become more sensitive to insulin. Pros Weight
More informationGLP-1 agonists. Ian Gallen Consultant Community Diabetologist Royal Berkshire Hospital Reading UK
GLP-1 agonists Ian Gallen Consultant Community Diabetologist Royal Berkshire Hospital Reading UK What do GLP-1 agonists do? Physiology of postprandial glucose regulation Meal ❶ ❷ Insulin Rising plasma
More informationSummary of the risk management plan (RMP) for Synjardy (empagliflozin / metformin)
EMA/217413/2015 Summary of the risk management plan (RMP) for Synjardy (empagliflozin / metformin) This is a summary of the risk management plan (RMP) for Synjardy, which details the measures to be taken
More informationHow can we improve outcomes in Type 2 diabetes?
How can we improve outcomes in Type 2 diabetes? Earlier diagnosis Better patient education Stress central role of lifestyle management Identify and treat all risk factors Use rational pharmacological therapy
More informationDiabetes Mellitus. Medical Management and Latest Developments Dr Ahmad Abou-Saleh
Diabetes Mellitus Medical Management and Latest Developments Dr Ahmad Abou-Saleh What is Diabetes Mellitus? A disease characterised by a state of chronic elevation of blood glucose levels due to: - The
More informationBarns Medical Practice Service Specification: Diabetes
Barns Medical Practice Service Specification: Diabetes DEVELOPED June 2017 REVIEW DATE June 2019 Introduction Diabetes mellitus is a life-long progressive condition that can be controlled but not cured.
More informationDiabetes and stroke. What is the link between diabetes and stroke? What is diabetes? What are the symptoms of diabetes?
Call the Stroke Helpline: 0303 3033 100 or email: info@stroke.org.uk Diabetes and stroke Diabetes is a lifelong condition that occurs when your body cannot regulate the amount of sugar in your blood. If
More informationMANAGEMENT OF TYPE 2 DIABETES
MANAGEMENT OF TYPE 2 DIABETES 3 Month trial of lifestyle changes. Refer to DESMOND structured education programme. Set glycaemic target HbA1c < 7.0% (53mmol/mol) or individualised If HbA1c > 53mmol/mol
More informationNew and Emerging Therapies for Type 2 DM
Dale Clayton MHSc, MD, FRCPC Dalhousie University/Capital Health April 28, 2011 New and Emerging Therapies for Type 2 DM The science of today, is the technology of tomorrow. Edward Teller American Physicist
More informationGlucose Control drug treatments
Glucose Control drug treatments It should be noted that glitazones are under suspicion of precipitating acute cardiac events and current recommendations contraindicate the use of glitazones in patients
More informationNewer and Expensive treatment of diabetes. Endocrinology Visiting Associate Professor Institute of Medicine TUTH
Newer and Expensive treatment of diabetes Jyoti Bhattarai MD Endocrinology Visiting Associate Professor Institute of Medicine TUTH Four out of every five people with diabetes now live in developing countries.
More informationINJECTABLE THERAPY FOR THE TREATMENT OF DIABETES
INJECTABLE THERAPY FOR THE TREATMENT OF DIABETES ARSHNA SANGHRAJKA DIABETES SPECIALIST PRESCRIBING PHARMACIST OBJECTIVES EXPLORE THE TYPES OF INSULIN AND INJECTABLE DIABETES TREATMENTS AND DEVICES AVAILABLE
More informationHypoglyceamia and Exercise
Hypoglyceamia and Exercise Noreen Barker Diabetes Specialist Nurse May 2016 Hypoglyceamia What is a hypo? Why are we concerned? Signs and symptoms Treatments Causes Hypo unawareness Managing diabetes and
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Single Technology Appraisal. Canagliflozin in combination therapy for treating type 2 diabetes
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Single Technology Appraisal Canagliflozin in combination therapy for Final scope Remit/appraisal objective To appraise the clinical and cost effectiveness
More informationProfessor Rudy Bilous James Cook University Hospital
Professor Rudy Bilous James Cook University Hospital Rate per 100 patient years Rate per 100 patient years 16 Risk of retinopathy progression 16 Risk of developing microalbuminuria 12 12 8 8 4 0 0 5 6
More informationType 2 Diabetes Mellitus hypoglycaemic agents
Type 2 Diabetes Mellitus hypoglycaemic agents Name Metformin Drug Name (eg brand name) Metformin (Diaformin Diabex) Cost / PBS per 28d mth $10.24 (1.5g dly) 1000mg+500mg / $4.44+$5.80 Concerns? Lactic
More informationYOU HAVE DIABETES. Angie O Connor Community Diabetes Nurse Specialist 25th September 2013
YOU HAVE DIABETES Angie O Connor Community Diabetes Nurse Specialist 25th September 2013 Predicated 2015 figures are already met 1 in 20 have diabetes:1in8 over 60years old Definite Diagnosis is key Early
More informationThere have been important changes in diabetes care which may not be covered in undergraduate textbooks.
Diabetes Clinical update There have been important changes in diabetes care which may not be covered in undergraduate textbooks. Changes in the diagnosis of diabetes a) HbA1C Since 2011, World Health Organisation
More informationFARXIGA (dapagliflozin) Jardiance (empagliflozin) tablets. Synjardy (empagliflozin and metformin hydrochloride) tablets. GLUCOPHAGE* (metformin)
Type 2 Medications Drug Class How It Works Brand and Generic Names Manufacturers Usual Starting Dose The kidneys filter sugar and either absorb it back into your body for energy or remove it through your
More informationChief of Endocrinology East Orange General Hospital
Targeting the Incretins System: Can it Improve Our Ability to Treat Type 2 Diabetes? Darshi Sunderam, MD Darshi Sunderam, MD Chief of Endocrinology East Orange General Hospital Age-adjusted Percentage
More informationPLEASE CHECK FULL SPECIFIC PRODUCT CHARACTERISTICS FOR MORE DETAILED AND CURRENT INFORMATION:
Metformin Standard tablets Modified-release tablets Metformin 1g sachets Metformin liquid 500mg/5ml (avoid use as expensive) < 2.00 5.32 for 56 tabs 500mg 13.16 for 60 sachets > 120 Ketoacidosis General
More informationGLP-1. GLP-1 is produced by the L-cells of the gut after food intake in two biologically active forms It is rapidly degraded by DPP-4.
GLP-1 GLP-1 is produced by the L-cells of the gut after food intake in two biologically active forms It is rapidly degraded by DPP-4 Food intake éinsulin Gut églucose uptake Pancreas Beta cells Alpha cells
More informationDiabetes and stroke. What is diabetes? What are the symptoms of diabetes? Stroke Helpline: Website: stroke.org.uk
Stroke Helpline: 0303 3033 100 Website: stroke.org.uk Diabetes is a condition caused by too much sugar in your blood. There are over three million people in the UK who have diabetes. If it s not controlled
More informationDiabetes in the UK: Update on Diabetes Treatment and Care. Why is diabetes increasing? Obesity Increased waist circumference.
Update on Diabetes Treatment and Care Tahseen A Chowdhury Consultant Diabetologist Royal London and Mile End Hospitals Diabetes prevalence (thousands) Diabetes in the UK: 1995-21 3 25 2 15 1 5 Type 1 Type
More informationSTEP 3: Add or Substitute with one of
Prescribing of Hypoglycaemic Agents for Adult Patients with Type 2 Diabetes: Sunderland Refer to DESMOND Structured Education classes to promote Increased Physical Activity, Weight Loss and Calories Reduction
More informationOral Agents. Ian Gallen Consultant Community Diabetologist Royal Berkshire Hospital Reading UK
Oral Agents Ian Gallen Consultant Community Diabetologist Royal Berkshire Hospital Reading UK What would your ideal diabetes drug do? Effective in lowering HbA1c No hypoglycaemia No effect on weight/ weight
More informationTreatment Options for Diabetes: An Update
Treatment Options for Diabetes: An Update A/Prof. Marg McGill Manager, Diabetes Centre Dr. Ted Wu Staff Specialist Endocrinologist Diabetes Centre Centre of Health Professional Education Education Provider
More informationManagement of Type 2 Diabetes. Why Do We Bother to Achieve Good Control in DM2. Insulin Secretion. The Importance of BP and Glucose Control
Insulin Secretion Management of Type 2 Diabetes DG van Zyl Why Do We Bother to Achieve Good Control in DM2 % reduction 0-5 -10-15 -20-25 -30-35 -40 The Importance of BP and Glucose Control Effects of tight
More informationDisclosure. Learning Objectives. Case. Diabetes Update: Incretin Agents in Diabetes-When to Use Them? I have no disclosures to declare
Disclosure Diabetes Update: Incretin Agents in Diabetes-When to Use Them? I have no disclosures to declare Spring Therapeutics Update 2011 CSHP BC Branch Anar Dossa BScPharm Pharm D CDE April 20, 2011
More informationOral Treatments for Type 2 Diabetes. Prescribing Support Pharmacist
Oral Treatments for Type 2 Diabetes Prescribing Support Pharmacist Learning Outcomes Familiar with classes of oral hypoglycaemic agents (OHAs) used in controlling blood glucose levels When to use each
More informationArrange 3 Monthly Review Re-enforce LIFESTYLE advice and check DRUG COMPLIANCE at each visit Target HbA1c < 53mmol/mol
Prescribing of Hypoglycaemic Agents for Adult Patients with Type 2 Diabetes: Sunderland Refer to DESMOND Structured Education classes to promote Increased Physical Activity, Weight Loss and Calories Reduction
More informationType 2 Diabetes. Stopping Smoking. Consider referral to smoking cessation. Consider referring for weight management advice.
Type 2 Diabetes Stopping Smoking Consider referral to smoking cessation BMI > 25 kg m² Set a weight loss target of a 5-10% reduction Consider referring for weight management advice Control BP to
More informationDr Tahseen A. Chowdhury Royal London Hospital. New Guidelines in Diabetes: NICE or Nasty?
Dr Tahseen A. Chowdhury Royal London Hospital New Guidelines in Diabetes: NICE or Nasty? I have no conflicts of interest I do not undertake talks / advisory bodies / research for any pharma company Consultant
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Proposed Health Technology Appraisal
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Proposed Health Technology Appraisal Dapagliflozin in combination therapy for the Final scope Remit/appraisal objective To appraise the clinical and
More informationOral Treatments. SaminaAli Prescribing Support Pharmacist
Oral Treatments for Type 2 Diabetes SaminaAli Prescribing Support Pharmacist Learning Outcomes National Guidance Familiar with classes of oral hypoglycaemic agents (OHAs) used in controlling blood glucose
More informationPATIENT INFORMATION LEAFLET MEDICINE TO TREAT: DIABETES
PATIENT INFORMATION LEAFLET MEDICINE TO TREAT: DIABETES α-glucosidase inhibitor Biguanide DPP-IV inhibitor Meglitinide Sulphonylurea SGLT-2 Inhibitors 1. What are these medicines used for? These medicines
More informationWhat the Pill Looks Like. How it Works. Slows carbohydrate absorption. Reduces amount of sugar made by the liver. Increases release of insulin
Diabetes s Oral s - Pills These are some of the pills that are currently available in Canada to treat diabetes. Each medication has benefits and side effects you should be aware of. Your diabetes team
More informationOptimal glucose control. DM Treatment. Glucose Control one out of many. Many guidelines: Confusing. Theorectically easy
DM Treatment How to Achieve Optimal Glycaemic Control The Tung Wah Eastern Hospital Experience of DM Share Care Experience Optimal glucose control Theorectically easy More challenging in the real world
More informationType 2 Diabetes. What is diabetes? What is type 2 diabetes? What is type 1 diabetes? Understanding blood glucose and insulin
Page 1 of 7 Type 2 Diabetes Type 2 diabetes occurs mainly in people aged over 40. The first-line treatment is diet, weight control and physical activity. If the blood sugar (glucose) level remains high
More informationDrugs used in Diabetes. Dr Andrew Smith
Drugs used in Diabetes Dr Andrew Smith Plan Introduction Insulin Sensitising Drugs: Metformin Glitazones Insulin Secretagogues: Sulphonylureas Meglitinides Others: Acarbose Incretins Amylin Analogues Damaglifozin
More informationOral and Injectable Non-insulin Antihyperglycemic Agents
Appendix 5: Diabetes Education and Medical Management in Adults with Diabetes Oral and Injectable Non-insulin s This directive will be implemented by RPhs, RNs or RDs who have been deemed authorized implementers.
More informationIMPROVED DIAGNOSIS OF TYPE 2 DIABETES AND TAILORING MEDICATIONS
IMPROVED DIAGNOSIS OF TYPE 2 DIABETES AND TAILORING MEDICATIONS Dr Bidhu Mohapatra, MBBS, MD, FRACP Consultant Physician Endocrinology and General Medicine Introduction 382 million people affected by diabetes
More informationPractical Strategies for the Clinical Use of Incretin Mimetics CME/CE. CME/CE Released: 09/15/2009; Valid for credit through 09/15/2010
Practical Strategies for the Clinical Use of Incretin Mimetics CME/CE Robert R. Henry, MD Authors and Disclosures CME/CE Released: 09/15/2009; Valid for credit through 09/15/2010 Introduction Type 2 diabetes
More informationDR HJ BODANSKY MD FRCP CONSULTANT PHYSICIAN LEEDS TEACHING HOSPITALS ASSOCIATE PROFESSOR, UNIVERSITY OF LEEDS
DR HJ BODANSKY MD FRCP CONSULTANT PHYSICIAN LEEDS TEACHING HOSPITALS ASSOCIATE PROFESSOR, UNIVERSITY OF LEEDS DIABETETES UPDATE 2015 AIMS OF THE SEMINAR Diagnosis Investigation Management When to refer
More informationDr A Pokrajac MD MSc MRCP Consultant
Dr A Pokrajac MD MSc MRCP Consultant Onset at 5-15 years of T1DM Can be present at diagnosis of T2DM Detect in regular MA/Cr screening (2X first urine sample, no UTI, no other causes) Contributing Factors
More informationINJECTABLE THERAPIES IN DIABETES. Barbara Ann McKee Diabetes Specialist Nurse
INJECTABLE THERAPIES IN DIABETES Barbara Ann McKee Diabetes Specialist Nurse 1 Aims of the session Describe the different injectable agents for diabetes and when they would be used. Describe some common
More informationThe Many Faces of T2DM in Long-term Care Facilities
The Many Faces of T2DM in Long-term Care Facilities Question #1 Which of the following is a risk factor for increased hypoglycemia in older patients that may suggest the need to relax hyperglycemia treatment
More informationWhat s New in Diabetes Medications. Jena Torpin, PharmD
What s New in Diabetes Medications Jena Torpin, PharmD 1 Objectives Discuss new medications in the management of diabetes Understand the mechanism of the medications discussed Understand the side effects
More informationOverview T2DM medications. Winnie Ho
Overview T2DM medications Winnie Ho Diabetes in Australia 1.7 million Australians with diabetes, of these 85% have T2DM 2-fold excess risk CV death in patients with diabetes Risk factor for progression
More informationNewer Drugs in the Management of Type 2 Diabetes Mellitus
Newer Drugs in the Management of Type 2 Diabetes Mellitus Dr. C. Dinesh M. Naidu Professor of Pharmacology, Kamineni Institute of Medical Sciences, Narketpally. 1 Presentation Outline Introduction Pathogenesis
More informationDiabetes Risk Assessment and Treatment
Diabetes Risk Assessment and Treatment Todd T. Brown, MD, PhD Professor of Medicine and Epidemiology Division of Endocrinology, Diabetes, & Metabolism Johns Hopkins University Baltimore, Maryland, USA
More informationPharmacological Glycaemic Control in Type 2 Diabetes
Pharmacological Glycaemic Control in Type 2 Diabetes Aim(s) and Objective(s) This guideline aims to offer advice on the pharmacological management for those who require measures beyond diet and exercise
More informationGuidelines to assist General Practitioners in the Management of Type 2 Diabetes. April 2010
Guidelines to assist General Practitioners in the Management of Type 2 Diabetes April 2010 Foreword The guidelines were devised by the Diabetes Day Centre in Beaumont Hospital in consultation with a number
More informationCommon Diabetes-related Terms
Common Diabetes-related Terms A1C An A1C test measures a person's average blood glucose level over two to three months. Hemoglobin is the part of a red blood cell that carries oxygen to the cells and sometimes
More informationObjectives. How Medicine Works to Control Blood Sugar Levels. What Happens When We Eat? What is diabetes? High Blood Glucose (Hyperglycemia)
How Medicine Works to Control Blood Sugar Levels Stacie Petersen, RN, CDE Objectives Define Diabetes List how medications work (ominous octet) Identify side effects of medications for diabetes What is
More informationWayne Gravois, MD August 6, 2017
Wayne Gravois, MD August 6, 2017 Americans with Diabetes (Millions) 40 30 Source: National Diabetes Statistics Report, 2011, 2017 Millions 20 10 0 1980 2009 2015 2007 - $174 Billion 2015 - $245 Billion
More informationDiabetes Oral Agents Pharmacology. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D
Diabetes Oral Agents Pharmacology University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D 1 Learning Objectives Understand the role of the utilization of free
More informationPathogenesis of Type 2 Diabetes
9/23/215 Multiple, Complex Pathophysiological Abnmalities in T2DM incretin effect gut carbohydrate delivery & absption pancreatic insulin secretion pancreatic glucagon secretion HYPERGLYCEMIA? Pathogenesis
More informationDiabetes mellitus is when the pancreas (a gland near the stomach) does not produce enough insulin to properly regulate blood glucose levels.
DIABETES MELLITUS What is Diabetes Mellitus? Level 1, 26 Robertson St Kensington 3031 VIC Australia T (03) 9092 0400 F (03) 9376 8567 info@advancedvetcare.com.au... ABN 29 814 586 915 Diabetes mellitus
More informationDiabetes Mellitus case studies. Jana Vinklerová
Diabetes Mellitus case studies Jana Vinklerová Definition of diabetes (metabolic disorder) Chronically raised blood glucose (hyperglycaemia) Insulin/Glucagon Insulin is responsible for lowering glucose
More informationDrug Class Review Newer Diabetes Medications and Combinations
Drug Class Review Newer Diabetes Medications and Combinations Final Update 2 Report July 2016 The purpose reports is to make available information regarding the comparative clinical effectiveness and harms
More informationWhat s New in Diabetes Treatment. Disclosures
What s New in Diabetes Treatment Shiri Levy M.D. Henry Ford Hospital Senior Staff Physician Service Chief, West Bloomfield Hospital Endocrinology, Metabolism, Bone and Mineral Disorders Disclosures None
More informationSitagliptin: first DPP-4 inhibitor to treat type 2 diabetes Steve Chaplin MSc, MRPharmS and Andrew Krentz MD, FRCP
Sitagliptin: first DPP-4 inhibitor to treat type 2 diabetes Steve Chaplin MSc, MRPharmS and Andrew Krentz MD, FRCP KEY POINTS sitagliptin (Januvia) is a DPP-4 inhibitor that blocks the breakdown of the
More informationDiabetes Mellitus. Disclaimer. Multimedia Health Education
Disclaimer This movie is an educational resource only and should not be used to manage Diabetes or blood sugar control.all decisions about management of diabetes must be made in conjunction with your Physician
More informationThe Endocrine Pancreas (Chapter 10) *
OpenStax-CNX module: m62118 1 The Endocrine Pancreas (Chapter 10) * Ildar Yakhin Based on The Endocrine Pancreas by OpenStax This work is produced by OpenStax-CNX and licensed under the Creative Commons
More informationWhat is diabetes? INSULIN, WHAT DOES IT DO?
What is diabetes? Type 2 diabetes is when the body is unable to use insulin effectively due to resistance to insulin. The cells in the pancreas that make insulin still produce insulin but the insulin is
More informationSIOFOR mg film-coated tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER SIOFOR 1000 1000mg film-coated tablets For use in children from 10 years and adults METFORMIN HYDROCHLORIDE This leaflet is a copy of the Summary of Product Characteristics
More informationMembers Sweet Meet Diabetes Update 6 May Sarita Naik Consultant in Diabetes and Endocrinology
Members Sweet Meet Diabetes Update 6 May 2014 Sarita Naik Consultant in Diabetes and Endocrinology Some of the myths. Should you be having that cake? People with diabetes can t lead normal lives Eating
More informationSIOFOR mg film-coated tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER SIOFOR 850 850mg film-coated tablets METFORMIN HYDROCHLORIDE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for
More informationHow many spoonfuls of sugar? A Bert s-eye view of prescribing to manage blood sugar
How many spoonfuls of sugar? A Bert s-eye view of prescribing to manage blood sugar What would Mary Poppins think? Please discuss Some Sums Annual cost of diabetes (1 &2) in England = c. 24 billion Around
More informationDIABETES AND RAMADAN FASTING
DIABETES AND RAMADAN FASTING Dr. A. Nigam, M.B.B.S., M.D. (Medicine) Specialist Internal Medicine Al Zahrawi Hospital, Ras Al Khaimah, U.A.E. It is estimated that UAE s population currently stands at approximately
More informationWhat is diabetes? Community Health Education Lecture Series November 18, Cara L. Kilroy, ANP-BC
What is diabetes? Community Health Education Lecture Series November 18, 2014 Cara L. Kilroy, ANP-BC About Diabetes Total prevalence of diabetes Total: 25.8 million children and adults in the United States
More informationUpdate on GLP-1 Past Present Future
Update on GLP-1 p Past Present Future Effects of GLP-1: Glucose Metabolism and Nutritional Balance L-Cells: Glp-1 release Betacellfollowing ingestion Stress Increases satiety reduces appetite Betacell-
More informationDIABETES. overview of pharmacologic agents used in the management of. Overview 4/3/2014 OBJECTIVES. Injectable Agents
overview of pharmacologic agents used in the management of DIABETES Kyle Roberts, Pharm.D. PGY-1 Pharmacy Resident Saint Alphonsus RMC 1. List the different classes of diabetes medications, including the
More information667FM.5.1 MANAGEMENT OF TYPE 2 DIABETES: BLOOD-GLUCOSE-LOWERING THERAPY
667FM.5.1 MANAGEMENT OF TYPE 2 DIABETES: BLOOD-GLUCOSE-LOWERING THERAPY Contents Introduction... 1 Patient Education for People with Type 2 Diabetes... 2 Dietary Advice for People with Type 2 Diabetes...
More informationShould Psychiatrists be diagnosing (and treating) metabolic syndrome
Should Psychiatrists be diagnosing (and treating) metabolic syndrome David Hopkins Clinical Director, Diabetes King s College Hospital, London Diabetes prevalence (thousands) Diabetes in the UK: 1995-2010
More informationDiabesity. Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs
Diabesity Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs Abdominal obesity Low HDL, high LDL, and high triglycerides HTN High blood glucose (F>100l,
More informationDiabetes. For Employees of the Randolph County School System
Diabetes For Employees of the Randolph County School System Diabetes Early detection and treatment of diabetes can decrease the risk of developing complications of diabetes Some symptoms of diabetes are
More informationObjectives 10/11/2013. Diabetes- The Real Cost of Sugar. Diabetes 101: What is Diabetes. By Ruth Nekonchuk RD CDE LMNT
Diabetes- The Real Cost of Sugar By Ruth Nekonchuk RD CDE LMNT Objectives To explain diabetes To explain the risks of diabetes To enumerate the cost of diabetes to our country To enumerate the cost of
More informationSummary of the risk management plan (RMP) for Ebymect (dapagliflozin / metformin)
EMA/672415/2015 Summary of the risk management plan (RMP) for Ebymect (dapagliflozin / metformin) This is a summary of the risk management plan (RMP) for Ebymect, which details the measures to be taken
More informationEssential advice for people with diabetes from Accu-Chek. The inside story on diabetes
Essential advice for people with diabetes from Accu-Chek The inside story on diabetes What is diabetes? Glucose is a form of sugar that is found in food you eat. It is a vital energy source for your body
More informationLiraglutide (Victoza) in combination with basal insulin for type 2 diabetes
Liraglutide (Victoza) in combination with basal insulin for type 2 diabetes May 2011 This technology summary is based on information available at the time of research and a limited literature search. It
More informationInformation for Patients
Information for Patients Guidance for Diabetic Persons having an OGD or Bronchoscopy This guidance is provided to assist with your preparation for your endoscopic procedure. If you feel unclear about how
More informationsitagliptin, 25mg, 50mg and 100mg film-coated tablets (Januvia ) SMC No. (1083/15) Merck Sharp and Dohme UK Ltd
sitagliptin, 25mg, 50mg and 100mg film-coated tablets (Januvia ) SMC No. (1083/15) Merck Sharp and Dohme UK Ltd 07 August 2015 The Scottish Medicines Consortium (SMC) has completed its assessment of the
More informationI. General Considerations
1 2 3 I. General Considerations A. Type I ( Juvenile Onset or IDDM) IDDM results from autoimmune destruction of beta cells inability to secrete insulin --> ketone formation --> DKA 4 Diabetic Ketoacidosis
More informationDiabetes Medications: Oral Anti-Hyperglycemic Medications
Diabetes Medications: Oral Anti-Hyperglycemic Medications Medication Types 1. Biguanides 2. Sulfonylureas 3. Thiazolidinediones (TZDs) 4. Alpha-Glucosidase Inhibitors 5. D-Phenylalanine Meglitinides 6.
More informationHypoglycemia. When recognized early, hypoglycemia can be treated successfully.
Hypoglycemia Introduction Hypoglycemia is a condition that causes blood sugar level to drop dangerously low. It mostly shows up in diabetic patients who take insulin. When recognized early, hypoglycemia
More informationVictoza (liraglutide) solution for injection 6 mg/ml
Page: 1 of 11 Victoza (liraglutide) solution for injection 6 mg/ml Summary of the risk management plan (RMP) for Victoza Author: Novo Nordisk Pharma AG Page: 2 of 11 Table of Contents Page Table of Contents...
More informationDrug Class Review Monograph GPI Class 27 Anti-diabetics
Drug Class Review Monograph GPI Class 27 Anti-diabetics Review Time Frame: 11/2015 04/2017 Previous Class Review: 02/2016 Background: Antidiabetic drug classes include: Alpha-glucosidase inhibitors- slow
More informationDiabetes-Facing it Head On! Going for the 3 Increases: Increase in Health, Increase in Happiness & Increase in Energy
Diabetes-Facing it Head On! Going for the 3 Increases: Increase in Health, Increase in Happiness & Increase in Energy Strategies for Success in Health Management By: James J. Messina, Ph.D. What is Type
More informationDiabetes Workbook Level 3
Diabetes Workbook Level 3 Contents Diabetes Workbook 02 Pre Training Quiz 03 1. 04 2. 06 3. 08 4. 15 5. 16 This workbook was put together by Su Down, Nurse Consultant Diabetes, Somerset Partnership NHS
More informationPERIOPERATIVE DIABETES GUIDELINE
PERIOPERATIVE DIABETES GUIDELINE This Guideline does not replace the need for the application of clinical judgment in respect to each individual patient. Background Diabetes mellitus is estimated to affect
More informationInjectable GLP 1 therapy: weight loss effects seen in obesity with and without diabetes
Injectable GLP 1 therapy: weight loss effects seen in obesity with and without diabetes Dr Masud Haq Consultant Lead in Diabetes & Endocrinology Maidstone & Tunbridge Wells NHS Trust & The London Preventative
More informationGLP-1-based therapies in the management of type 2 diabetes
GLP-1-based therapies in the management of type 2 diabetes Makbul Aman Mansyur Division Endocrine & Metabolism Department of Internal Medicine Faculty of Medicine Hasanuddin University/ RSUP Dr. Wahidin
More informationSide Effects of: GLP-1 agonists DPP-4 inhibitors SGLT-2 inhibitors. Bryce Fukunaga PharmD April 25, 2018
Side Effects of: GLP-1 agonists DPP-4 inhibitors SGLT-2 inhibitors Bryce Fukunaga PharmD April 25, 2018 Objectives For each drug class: Identify the overall place in therapy Explain the mechanism of action
More information